C21 Investments Inc
General ticker "CXXIF" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $24.8M
C21 Investments Inc does not follow the US Stock Market performance with the rate: -31.4%.
Estimated limits based on current volatility of 5.7%: low 0.18$, high 0.20$
Factors to consider:
- Earnings for 12 months up through Q4 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-01-31 to 2025-01-30
- 2023-01-31 to 2024-01-31 estimated range: [0.11$, 0.25$]
- 2024-01-31 to 2025-01-30 estimated range: [0.10$, 0.22$]
Financial Metrics affecting the CXXIF estimates:
- Negative: Non-GAAP EPS, $ of 0.01 <= 0.10
- Positive: Operating cash flow per share per price, % of 22.86 > 12.76
- Positive: 9.05 < Operating profit margin, % of 13.69
- Positive: Interest expense per share, $ of 0 <= 0.14
- Negative: Inventory ratio change, % of 1.43 > 1.08
- Negative: Industry operating cash flow per share per price (median), % of -15.45 <= 3.85
- Positive: -0.25 < Return on assets ratio (scaled to [-100,100]) of 2.31
Short-term CXXIF quotes
Long-term CXXIF plot with estimates
Financial data
| YTD | 2022-01-31 | 2023-01-31 |
|---|---|---|
| Operating Revenue | $32.98MM | $28.89MM |
| Operating Expenses | $23.23MM | $24.93MM |
| Operating Income | $9.75MM | $3.96MM |
| Non-Operating Income | $7.38MM | $0.24MM |
| Interest Expense | $1.31MM | $0.46MM |
| Income(Loss) | $17.13MM | $4.19MM |
| Taxes | $3.97MM | $2.81MM |
| Profit(Loss) | $13.16MM | $1.38MM |
| Stockholders Equity | $34.98MM | $34.32MM |
| Inventory | $4.05MM | $4.17MM |
| Assets | $61.85MM | $58.31MM |
| Operating Cash Flow | $6.84MM | $5.90MM |
| Capital expenditure | $2.56MM | $0.44MM |
| Investing Cash Flow | $-1.39MM | $-0.39MM |
| Financing Cash Flow | $-7.84MM | $-6.68MM |
| Earnings Per Share* | $0.08 | $0.01 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.